Lv1
30 积分 2026-06-27 加入
Discovery of LOU064 (Remibrutinib), a Potent and Highly Selective Covalent Inhibitor of Bruton's Tyrosine Kinase
1个月前
已完结
Sex matters: impact on pathogenesis, presentation and treatment of inflammatory bowel disease
2个月前
已完结
Differential diagnosis of inflammatory bowel disease: imitations and complications
2个月前
已完结
Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis
2个月前
已完结
Epidemiology and risk factors for IBD
3个月前
已完结
The global burden of IBD: from 2015 to 2025
3个月前
已完结
皖公网安备34019202002308
